Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry
出版年份 2017 全文链接
标题
Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry
作者
关键词
-
出版物
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
Volume 19, Issue 4, Pages 244-328
出版商
Informa UK Limited
发表日期
2017-10-27
DOI
10.1080/15622975.2017.1375556
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis
- (2017) David J Irwin et al. LANCET NEUROLOGY
- Ex vivo 18O-labeling mass spectrometry identifies a peripheral amyloid β clearance pathway
- (2017) Erik Portelius et al. Molecular Neurodegeneration
- A review on neuroimaging-based classification studies and associated feature extraction methods for Alzheimer's disease and its prodromal stages
- (2017) Saima Rathore et al. NEUROIMAGE
- Preclinical amyloid pathology biomarker positivity: effects on tau pathology and neurodegeneration
- (2017) K Höglund et al. Translational Psychiatry
- The Neuropathology of Older Persons with and Without Dementia from Community versus Clinic Cohorts
- (2017) Julie A. Schneider et al. JOURNAL OF ALZHEIMERS DISEASE
- Biomarkers as Predictors for Conversion from Mild Cognitive Impairment to Alzheimer-Type Dementia: Implications for Trial Design
- (2017) Ineke A. van Rossum et al. JOURNAL OF ALZHEIMERS DISEASE
- Type 2 Diabetes Mellitus, Dyslipidemia, and Alzheimer's Disease
- (2017) Cynthia M. Carlsson JOURNAL OF ALZHEIMERS DISEASE
- CSF biomarkers associated with disease heterogeneity in early Parkinson’s disease: the Parkinson’s Progression Markers Initiative study
- (2016) Ju-Hee Kang et al. ACTA NEUROPATHOLOGICA
- Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status
- (2016) Laura Piccio et al. ACTA NEUROPATHOLOGICA
- Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer’s disease
- (2016) Raj N. Kalaria ACTA NEUROPATHOLOGICA
- Advances in the development of tau PET radiotracers and their clinical applications
- (2016) Nobuyuki Okamura et al. AGEING RESEARCH REVIEWS
- Amyloid imaging: Past, present and future perspectives
- (2016) Victor L. Villemagne AGEING RESEARCH REVIEWS
- Performance and complications of lumbar puncture in memory clinics: Results of the multicenter lumbar puncture feasibility study
- (2016) Flora H. Duits et al. Alzheimers & Dementia
- Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of β-amyloid (1–42) in human cerebrospinal fluid
- (2016) Tobias Bittner et al. Alzheimers & Dementia
- Blood metabolite markers of preclinical Alzheimer's disease in two longitudinally followed cohorts of older individuals
- (2016) Ramon Casanova et al. Alzheimers & Dementia
- Ethical challenges in preclinical Alzheimer's disease observational studies and trials: Results of the Barcelona summit
- (2016) José L. Molinuevo et al. Alzheimers & Dementia
- Alzheimer's disease risk variants modulate endophenotypes in mild cognitive impairment
- (2016) Eva Louwersheimer et al. Alzheimers & Dementia
- Subjective memory decline predicts greater rates of clinical progression in preclinical Alzheimer's disease
- (2016) Rachel F. Buckley et al. Alzheimers & Dementia
- Round robin test on quantification of amyloid-β 1–42 in cerebrospinal fluid by mass spectrometry
- (2016) Josef Pannee et al. Alzheimers & Dementia
- Imaging and cerebrospinal fluid biomarkers in early preclinical alzheimer disease
- (2016) Andrei G. Vlassenko et al. ANNALS OF NEUROLOGY
- Dendritic Spine Pathology in Neurodegenerative Diseases
- (2016) Jochen Herms et al. Annual Review of Pathology-Mechanisms of Disease
- The utility of α-synuclein as biofluid marker in neurodegenerative diseases: a systematic review of the literature
- (2016) Anja Hviid Simonsen et al. Biomarkers in Medicine
- Value of cerebrospinal fluid α-synuclein species as biomarker in Parkinson's diagnosis and prognosis
- (2016) Lucilla Parnetti et al. Biomarkers in Medicine
- Vascular cognitive impairment neuropathology guidelines (VCING): the contribution of cerebrovascular pathology to cognitive impairment
- (2016) Olivia A. Skrobot et al. BRAIN
- Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography
- (2016) Sebastian Palmqvist et al. BRAIN
- Regional profiles of the candidate tau PET ligand18F-AV-1451 recapitulate key features of Braak histopathological stages
- (2016) Adam J. Schwarz et al. BRAIN
- The relationship between cerebrospinal fluid markers of Alzheimer pathology and positron emission tomography tau imaging
- (2016) Brian A. Gordon et al. BRAIN
- The Prevalence and Incidence of Frontotemporal Dementia: a Systematic Review
- (2016) David B. Hogan et al. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
- The Cellular Phase of Alzheimer’s Disease
- (2016) Bart De Strooper et al. CELL
- Assessing the commutability of reference material formats for the harmonization of amyloid-β measurements
- (2016) Maria Bjerke et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers
- (2016) Marc Suárez‐Calvet et al. EMBO Molecular Medicine
- Cerebrospinal fluid markers in the differentiation of molecular subtypes of sporadic Creutzfeldt−Jakob disease
- (2016) K. Gmitterová et al. EUROPEAN JOURNAL OF NEUROLOGY
- Synaptic degeneration and neurogranin in the pathophysiology of Alzheimer’s disease
- (2016) Simone Lista et al. Expert Review of Neurotherapeutics
- Decreased synaptic proteins in neuronal exosomes of frontotemporal dementia and Alzheimer’s disease
- (2016) Edward J. Goetzl et al. FASEB JOURNAL
- Cargo proteins of plasma astrocyte-derived exosomes in Alzheimer’s disease
- (2016) Edward J. Goetzl et al. FASEB JOURNAL
- Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics
- (2016) Natalia Lelental et al. JOURNAL OF ALZHEIMERS DISEASE
- Added Prognostic Value of Cerebrospinal Fluid Biomarkers in Predicting Decline in Memory Clinic Patients in a Prospective Cohort
- (2016) Ron L.H. Handels et al. JOURNAL OF ALZHEIMERS DISEASE
- Cerebrospinal Fluid Alzheimer’s Disease Biomarkers in Isolated Supratentorial Cortical Superficial Siderosis
- (2016) Dimitri Renard et al. JOURNAL OF ALZHEIMERS DISEASE
- Blood-Based Biomarker Candidates of Cerebral Amyloid Using PiB PET in Non-Demented Elderly
- (2016) Sarah Westwood et al. JOURNAL OF ALZHEIMERS DISEASE
- Diagnostic Impact of Cerebrospinal Fluid Biomarker (Pre-)Analytical Variability in Alzheimer’s Disease
- (2016) Ellis Niemantsverdriet et al. JOURNAL OF ALZHEIMERS DISEASE
- Cerebrospinal Fluid Aβ42/40 Corresponds Better than Aβ42 to Amyloid PET in Alzheimer’s Disease
- (2016) Piotr Lewczuk et al. JOURNAL OF ALZHEIMERS DISEASE
- Neurochemical biomarkers in the diagnosis of frontotemporal lobar degeneration: an update
- (2016) Patrick Oeckl et al. JOURNAL OF NEUROCHEMISTRY
- Reference measurement procedure for CSF amyloid beta (Aβ)1-42and the CSF Aβ1-42/Aβ1-40ratio - a cross-validation study against amyloid PET
- (2016) Josef Pannee et al. JOURNAL OF NEUROCHEMISTRY
- Biological confounders for the values of cerebrospinal fluid proteins in Parkinson's disease and related disorders
- (2016) Brit Mollenhauer et al. JOURNAL OF NEUROCHEMISTRY
- Alzheimer's disease
- (2016) Philip Scheltens et al. LANCET
- CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
- (2016) Bob Olsson et al. LANCET NEUROLOGY
- Transition rates between amyloid and neurodegeneration biomarker states and to dementia: a population-based, longitudinal cohort study
- (2016) Clifford R Jack et al. LANCET NEUROLOGY
- Defeating Alzheimer's disease and other dementias: a priority for European science and society
- (2016) Bengt Winblad et al. LANCET NEUROLOGY
- Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study
- (2016) Samantha C Burnham et al. LANCET NEUROLOGY
- Alpha-, Beta-, and Gamma-synuclein Quantification in Cerebrospinal Fluid by Multiple Reaction Monitoring Reveals Increased Concentrations in Alzheimer′s and Creutzfeldt-Jakob Disease but No Alteration in Synucleinopathies
- (2016) Patrick Oeckl et al. MOLECULAR & CELLULAR PROTEOMICS
- No diurnal variation of classical and candidate biomarkers of Alzheimer’s disease in CSF
- (2016) Claudia Cicognola et al. Molecular Neurodegeneration
- Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease
- (2016) Nour K. Majbour et al. Molecular Neurodegeneration
- Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer’s disease
- (2016) Amanda Heslegrave et al. Molecular Neurodegeneration
- Genome-wide significant risk factors for Alzheimer’s disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment
- (2016) A Lacour et al. MOLECULAR PSYCHIATRY
- Protein biomarkers in Parkinson's disease: Focus on cerebrospinal fluid markers and synaptic proteins
- (2016) Steffen Halbgebauer et al. MOVEMENT DISORDERS
- The real-time quaking-induced conversion assay for detection of human prion disease and study of other protein misfolding diseases
- (2016) Matthias Schmitz et al. Nature Protocols
- TREM2 variants: new keys to decipher Alzheimer disease pathogenesis
- (2016) Marco Colonna et al. NATURE REVIEWS NEUROSCIENCE
- Evolution of neurodegeneration-imaging biomarkers from clinically normal to dementia in the Alzheimer disease spectrum
- (2016) David S. Knopman et al. NEUROBIOLOGY OF AGING
- Assessment of the genetic variance of late-onset Alzheimer's disease
- (2016) Perry G. Ridge et al. NEUROBIOLOGY OF AGING
- NIA-AA staging of preclinical Alzheimer disease: discordance and concordance of CSF and imaging biomarkers
- (2016) Stephanie J.B. Vos et al. NEUROBIOLOGY OF AGING
- A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers
- (2016) Clifford R. Jack et al. NEUROLOGY
- Heterogeneous histopathology of cortical microbleeds in cerebral amyloid angiopathy
- (2016) Susanne J. van Veluw et al. NEUROLOGY
- Increased CSF neurogranin concentration is specific to Alzheimer disease
- (2016) Henrietta Wellington et al. NEUROLOGY
- Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia
- (2016) Jonathan D. Rohrer et al. NEUROLOGY
- Temporal T807 binding correlates with CSF tau and phospho-tau in normal elderly
- (2016) Jasmeer P. Chhatwal et al. NEUROLOGY
- Neurofilament Light: A Dynamic Cross-Disease Fluid Biomarker for Neurodegeneration
- (2016) Henrik Zetterberg NEURON
- Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases
- (2016) Mehtap Bacioglu et al. NEURON
- PET Imaging of Tau Deposition in the Aging Human Brain
- (2016) Michael Schöll et al. NEURON
- Sporadic Creutzfeldt–Jakob disease diagnostic accuracy is improved by a new CSF ELISA 14-3-3γ assay
- (2016) M.J. Leitão et al. NEUROSCIENCE
- Tau and Aβ imaging, CSF measures, and cognition in Alzheimer’s disease
- (2016) Matthew R. Brier et al. Science Translational Medicine
- A single dose of the γ-secretase inhibitor semagacestat alters the cerebrospinal fluid peptidome in humans
- (2016) Mikko Hölttä et al. Alzheimers Research & Therapy
- Synaptic degeneration and neurogranin in the pathophysiology of Alzheimer’s disease
- (2016) Simone Lista et al. Expert Review of Neurotherapeutics
- Heterogeneity in Suspected Non–Alzheimer Disease Pathophysiology Among Clinically Normal Older Individuals
- (2016) Elizabeth C. Mormino et al. JAMA Neurology
- Longitudinal β-Amyloid Deposition and Hippocampal Volume in Preclinical Alzheimer Disease and Suspected Non–Alzheimer Disease Pathophysiology
- (2016) Brian A. Gordon et al. JAMA Neurology
- Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression
- (2016) Henrik Zetterberg et al. JAMA Neurology
- Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies
- (2016) Graham Fairfoul et al. Annals of Clinical and Translational Neurology
- Neurofilament light chain: a biomarker for genetic frontotemporal dementia
- (2016) Lieke H. Meeter et al. Annals of Clinical and Translational Neurology
- CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease
- (2016) Shorena Janelidze et al. Annals of Clinical and Translational Neurology
- Neuropathologically mixed Alzheimer’s and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes
- (2015) Lauren Walker et al. ACTA NEUROPATHOLOGICA
- Templated misfolding of Tau by prion-like seeding along neuronal connections impairs neuronal network function and associated behavioral outcomes in Tau transgenic mice
- (2015) Ilie-Cosmin Stancu et al. ACTA NEUROPATHOLOGICA
- Pathological α-synuclein distribution in subjects with coincident Alzheimer’s and Lewy body pathology
- (2015) Jon B. Toledo et al. ACTA NEUROPATHOLOGICA
- Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease
- (2015) Hlin Kvartsberg et al. Alzheimers & Dementia
- Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014
- (2015) Michael W. Weiner et al. Alzheimers & Dementia
- Early cost-utility analysis of general and cerebrospinal fluid-specific Alzheimer's disease biomarkers for hypothetical disease-modifying treatment decision in mild cognitive impairment
- (2015) Ron L.H. Handels et al. Alzheimers & Dementia
- The Alzheimer’s Disease Neuroimaging Initiative 2 Biomarker Core: A review of progress and plans
- (2015) Ju-Hee Kang et al. Alzheimers & Dementia
- 2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception
- (2015) Michael W. Weiner et al. Alzheimers & Dementia
- APOE effect on Alzheimer's disease biomarkers in older adults with significant memory concern
- (2015) Shannon L. Risacher et al. Alzheimers & Dementia
- A 22-single nucleotide polymorphism Alzheimer's disease risk score correlates with family history, onset age, and cerebrospinal fluid Aβ 42
- (2015) Kristel Sleegers et al. Alzheimers & Dementia
- Diagnostic impact of CSF biomarkers for Alzheimer's disease in a tertiary memory clinic
- (2015) Flora H. Duits et al. Alzheimers & Dementia
- CSF biomarkers for the differential diagnosis of Alzheimer's disease: A large-scale international multicenter study
- (2015) Michael Ewers et al. Alzheimers & Dementia
- Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease research
- (2015) Sid E. O'Bryant et al. Alzheimers & Dementia
- Convergent genetic and expression data implicate immunity in Alzheimer's disease
- (2015) Lesley Jones et al. Alzheimers & Dementia
- C-terminal neurogranin is increased in cerebrospinal fluid but unchanged in plasma in Alzheimer's disease
- (2015) Ann De Vos et al. Alzheimers & Dementia
- Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study
- (2015) Massimo S. Fiandaca et al. Alzheimers & Dementia
- Neurofilament levels as biomarkers in asymptomatic and symptomatic familial amyotrophic lateral sclerosis
- (2015) Patrick Weydt et al. ANNALS OF NEUROLOGY
- Tau positron emission tomographic imaging in aging and early Alzheimer disease
- (2015) Keith A. Johnson et al. ANNALS OF NEUROLOGY
- Cerebrospinal fluid proteomics and protein biomarkers in frontotemporal lobar degeneration: Current status and future perspectives
- (2015) Patrick Oeckl et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Clinical associations between gout and multiple sclerosis, Parkinson’s disease and motor neuron disease: record-linkage studies
- (2015) Julia Pakpoor et al. BMC Neurology
- Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer’s disease
- (2015) Erik Portelius et al. BRAIN
- Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly
- (2015) Prashanthi Vemuri et al. BRAIN
- Common polygenic variation enhances risk prediction for Alzheimer’s disease
- (2015) Valentina Escott-Price et al. BRAIN
- Cortical superficial siderosis: detection and clinical significance in cerebral amyloid angiopathy and related conditions
- (2015) Andreas Charidimou et al. BRAIN
- Prevalence and prognosis of Alzheimer’s disease at the mild cognitive impairment stage
- (2015) Stephanie J. B. Vos et al. BRAIN
- Different definitions of neurodegeneration produce similar amyloid/neurodegeneration biomarker group findings
- (2015) Clifford R. Jack et al. BRAIN
- The use of the 25 Sprotte needle markedly reduces post-dural puncture headache in routine neurological practice
- (2015) Antonio Bertolotto et al. CEPHALALGIA
- Standard biobanking conditions prevent evaporation of body fluid samples
- (2015) Eline A.J. Willemse et al. CLINICA CHIMICA ACTA
- Importance and Impact of Preanalytical Variables on Alzheimer Disease Biomarker Concentrations in Cerebrospinal Fluid
- (2015) N. Le Bastard et al. CLINICAL CHEMISTRY
- Diagnostic accuracy of 18F amyloid PET tracers for the diagnosis of Alzheimer’s disease: a systematic review and meta-analysis
- (2015) Elizabeth Morris et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Dysfunctionally phosphorylated type 1 insulin receptor substrate in neural-derived blood exosomes of preclinical Alzheimer’s disease
- (2015) Dimitrios Kapogiannis et al. FASEB JOURNAL
- The genetic landscape of Alzheimer disease: clinical implications and perspectives
- (2015) Caroline Van Cauwenberghe et al. GENETICS IN MEDICINE
- Potential utility of autoantibodies as blood-based biomarkers for early detection and diagnosis of Parkinson’s disease
- (2015) Cassandra A. DeMarshall et al. IMMUNOLOGY LETTERS
- Use of CSF α-synuclein in the differential diagnosis between Alzheimer's disease and other neurodegenerative disorders
- (2015) Zheng-Yu Wang et al. INTERNATIONAL PSYCHOGERIATRICS
- Prevalence of Amyloid PET Positivity in Dementia Syndromes
- (2015) Rik Ossenkoppele et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia
- (2015) Willemijn J. Jansen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cerebrospinal fluid profiles with increasing number of cerebral microbleeds in a continuum of cognitive impairment
- (2015) Sara Shams et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- A Consensus in Korea Regarding a Protocol to Reduce Preanalytical Sources of Variability in the Measurement of the Cerebrospinal Fluid Biomarkers of Alzheimer's Disease
- (2015) Sun Ah Park et al. Journal of Clinical Neurology
- Prognostic Role of Serum Levels of Uric Acid in Amyotrophic Lateral Sclerosis
- (2015) Seong-il Oh et al. Journal of Clinical Neurology
- A fully-automated, six-plex single molecule immunoassay for measuring cytokines in blood
- (2015) Andrew J. Rivnak et al. JOURNAL OF IMMUNOLOGICAL METHODS
- The expanding syndrome of amyotrophic lateral sclerosis: a clinical and molecular odyssey
- (2015) Martin R Turner et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Cerebrovascular injury as a risk factor for amyotrophic lateral sclerosis: Table 1
- (2015) Martin R Turner et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes
- (2015) N K Magdalinou et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Prion Disease Induces Alzheimer Disease—Like Neuropathologic Changes
- (2015) Thomas Tousseyn et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- The Potent BACE1 Inhibitor LY2886721 Elicits Robust Central A Pharmacodynamic Responses in Mice, Dogs, and Humans
- (2015) P. C. May et al. JOURNAL OF NEUROSCIENCE
- Label-Free LC–MS/MS Proteomic Analysis of Cerebrospinal Fluid Identifies Protein/Pathway Alterations and Candidate Biomarkers for Amyotrophic Lateral Sclerosis
- (2015) Mahlon A. Collins et al. JOURNAL OF PROTEOME RESEARCH
- Cerebrospinal fluid Aβ40 is similarly reduced in patients with Frontotemporal Lobar Degeneration and Alzheimer's Disease
- (2015) Inês Baldeiras et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Lewy body dementias
- (2015) Zuzana Walker et al. LANCET
- Frontotemporal dementia
- (2015) Jee Bang et al. LANCET
- Vascular dementia
- (2015) John T O'Brien et al. LANCET
- Tau imaging: early progress and future directions
- (2015) Victor L Villemagne et al. LANCET NEUROLOGY
- Clinical protein mass spectrometry
- (2015) Alexander Scherl METHODS
- Stability and Reproducibility Underscore Utility of RT-QuIC for Diagnosis of Creutzfeldt-Jakob Disease
- (2015) Maria Cramm et al. MOLECULAR NEUROBIOLOGY
- Validation of 14-3-3 Protein as a Marker in Sporadic Creutzfeldt-Jakob Disease Diagnostic
- (2015) Matthias Schmitz et al. MOLECULAR NEUROBIOLOGY
- PLD3 in non-familial Alzheimer's disease
- (2015) Stefanie Heilmann et al. NATURE
- Suspected non-AD pathology in mild cognitive impairment
- (2015) Laura E.M. Wisse et al. NEUROBIOLOGY OF AGING
- Total glutamine synthetase levels in cerebrospinal fluid of Alzheimer's disease patients are unchanged
- (2015) Nienke M. Timmer et al. NEUROBIOLOGY OF AGING
- Cerebrospinal fluid tau levels are a marker for molecular subtype in sporadic Creutzfeldt-Jakob disease
- (2015) André Karch et al. NEUROBIOLOGY OF AGING
- Subjective cognitive concerns, amyloid-β, and neurodegeneration in clinically normal elderly
- (2015) Rebecca E. Amariglio et al. NEUROLOGY
- Ethics of genetic and biomarker test disclosures in neurodegenerative disease prevention trials
- (2015) S. Y. H. Kim et al. NEUROLOGY
- Subjective cognitive decline is related to CSF biomarkers of AD in patients with MCI
- (2015) S. Wolfsgruber et al. NEUROLOGY
- Mild cognitive impairment with suspected nonamyloid pathology (SNAP): Prediction of progression
- (2015) A. Caroli et al. NEUROLOGY
- Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons
- (2015) Patricia A. Boyle et al. NEUROLOGY
- Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis
- (2015) C.-H. Lu et al. NEUROLOGY
- Altered lysosomal proteins in neural-derived plasma exosomes in preclinical Alzheimer disease
- (2015) Edward J. Goetzl et al. NEUROLOGY
- Amyloid precursor protein metabolism and inflammation markers in preclinical Alzheimer disease
- (2015) Daniel Alcolea et al. NEUROLOGY
- Neuropathologic assessment of participants in two multi-center longitudinal observational studies: The Alzheimer Disease Neuroimaging Initiative (ADNI) and the Dominantly Inherited Alzheimer Network (DIAN)
- (2015) Nigel J. Cairns et al. NEUROPATHOLOGY
- The relative contributions of disease label and disease prognosis to Alzheimer's stigma: A vignette-based experiment
- (2015) Rebecca Johnson et al. SOCIAL SCIENCE & MEDICINE
- Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer’s disease patients and healthy controls
- (2015) Hlin Kvartsberg et al. Alzheimers Research & Therapy
- Peripheral and central effects of γ-secretase inhibition by semagacestat in Alzheimer’s disease
- (2015) Rachelle S Doody et al. Alzheimers Research & Therapy
- The cost-effectiveness challenge: is it worth it?
- (2015) Martin Knapp Alzheimers Research & Therapy
- Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease
- (2015) Maartje I. Kester et al. JAMA Neurology
- Neurogranin Levels in Cerebrospinal Fluid
- (2015) Henrik Zetterberg et al. JAMA Neurology
- Association of Cerebrospinal Fluid Prion Protein Levels and the Distinction Between Alzheimer Disease and Creutzfeldt-Jakob Disease
- (2015) Aline Dorey et al. JAMA Neurology
- Targeting Prodromal Alzheimer Disease With Avagacestat
- (2015) Vladimir Coric et al. JAMA Neurology
- Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age
- (2015) Courtney L. Sutphen et al. JAMA Neurology
- Predicting Reduction of Cerebrospinal Fluid β-Amyloid 42 in Cognitively Healthy Controls
- (2015) Niklas Mattsson et al. JAMA Neurology
- The Central Biobank and Virtual Biobank of BIOMARKAPD: A Resource for Studies on Neurodegenerative Diseases
- (2015) Babette L. R. Reijs et al. Frontiers in Neurology
- Chasing the Effects of Pre-Analytical Confounders – A Multicenter Study on CSF-AD Biomarkers
- (2015) Maria João Leitão et al. Frontiers in Neurology
- Cerebrospinal Fluid Aβ40 Improves the Interpretation of Aβ42 Concentration for Diagnosing Alzheimer’s Disease
- (2015) Aline Dorey et al. Frontiers in Neurology
- Cerebrospinal Fluid P-Tau181P: Biomarker for Improved Differential Dementia Diagnosis
- (2015) Hanne Struyfs et al. Frontiers in Neurology
- Elevated Levels of IFN-γ in CSF and Serum of Patients with Amyotrophic Lateral Sclerosis
- (2015) Juan Liu et al. PLoS One
- Primary age-related tauopathy (PART): a common pathology associated with human aging
- (2014) John F. Crary et al. ACTA NEUROPATHOLOGICA
- Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson’s disease
- (2014) Min Shi et al. ACTA NEUROPATHOLOGICA
- PART and SNAP
- (2014) Clifford R. Jack ACTA NEUROPATHOLOGICA
- Frontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine
- (2014) David J. Irwin et al. ACTA NEUROPATHOLOGICA
- Risk of dementia and mild cognitive impairment in older people with subjective memory complaints: meta-analysis
- (2014) A. J. Mitchell et al. ACTA PSYCHIATRICA SCANDINAVICA
- How does additional diagnostic testing influence the initial diagnosis in patients with cognitive complaints in a memory clinic setting?
- (2014) Anouk P. Meijs et al. AGE AND AGEING
- Diagnostic Criteria for Vascular Cognitive Disorders
- (2014) Perminder Sachdev et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- The clinical use of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative
- (2014) José Luis Molinuevo et al. Alzheimers & Dementia
- Plasma proteins predict conversion to dementia from prodromal disease
- (2014) Abdul Hye et al. Alzheimers & Dementia
- APOE ε4: The most prevalent yet understudied risk factor for Alzheimer's disease
- (2014) Daniel M. Michaelson Alzheimers & Dementia
- A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
- (2014) Frank Jessen et al. Alzheimers & Dementia
- Increased CSF α-synuclein levels in Alzheimer's disease: Correlation with tau levels
- (2014) Sylvie Slaets et al. Alzheimers & Dementia
- Apolipoprotein E in Alzheimer's Disease: An Update
- (2014) Jin-Tai Yu et al. Annual Review of Neuroscience
- New perspectives on the role of tau in Alzheimer's disease. Implications for therapy
- (2014) Miguel Medina et al. BIOCHEMICAL PHARMACOLOGY
- Biobanking of CSF: International standardization to optimize biomarker development
- (2014) Charlotte E. Teunissen et al. CLINICAL BIOCHEMISTRY
- Mass Spectrometry-Based Candidate Reference Measurement Procedure for Quantification of Amyloid- in Cerebrospinal Fluid
- (2014) A. Leinenbach et al. CLINICAL CHEMISTRY
- The Importance of Amyloid β Protein in Cerebrospinal Fluid when You Recognize Convexal Subarachnoid Hemorrhage
- (2014) Ryota Tamura et al. EUROPEAN NEUROLOGY
- SUCLG2 identified as both a determinator of CSF Aβ1–42 levels and an attenuator of cognitive decline in Alzheimer's disease
- (2014) Alfredo Ramirez et al. HUMAN MOLECULAR GENETICS
- Health economic evaluation of treatments for Alzheimer′s disease: impact of new diagnostic criteria
- (2014) A. Wimo et al. JOURNAL OF INTERNAL MEDICINE
- Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014
- (2014) L. S. Schneider et al. JOURNAL OF INTERNAL MEDICINE
- Challenges of multimorbidity of the aging brain: a critical update
- (2014) Kurt A. Jellinger et al. JOURNAL OF NEURAL TRANSMISSION
- Plasma neurofilament heavy chain levels and disease progression in amyotrophic lateral sclerosis: insights from a longitudinal study
- (2014) Ching-Hua Lu et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Intact Protein Analysis of Ubiquitin in Cerebrospinal Fluid by Multiple Reaction Monitoring Reveals Differences in Alzheimer’s Disease and Frontotemporal Lobar Degeneration
- (2014) Patrick Oeckl et al. JOURNAL OF PROTEOME RESEARCH
- Assessment of CSF Aβ42 as an aid to discriminating Alzheimer's disease from other dementias and mild cognitive impairment: A meta-analysis of 50 studies
- (2014) Wei Tang et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Age-specific population frequencies of cerebral β-amyloidosis and neurodegeneration among people with normal cognitive function aged 50–89 years: a cross-sectional study
- (2014) Clifford R Jack et al. LANCET NEUROLOGY
- Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
- (2014) Bruno Dubois et al. LANCET NEUROLOGY
- Prognostic serum miRNA biomarkers associated with Alzheimer’s disease shows concordance with neuropsychological and neuroimaging assessment
- (2014) L Cheng et al. MOLECULAR PSYCHIATRY
- The prevalence of Parkinson's disease: A systematic review and meta-analysis
- (2014) Tamara Pringsheim et al. MOVEMENT DISORDERS
- Plasma phospholipids identify antecedent memory impairment in older adults
- (2014) Mark Mapstone et al. NATURE MEDICINE
- Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases
- (2014) Alberto Lleó et al. Nature Reviews Neurology
- Skin nerve -synuclein deposits: A biomarker for idiopathic Parkinson disease
- (2014) V. Donadio et al. NEUROLOGY
- Rates of -amyloid accumulation are independent of hippocampal neurodegeneration
- (2014) C. R. Jack et al. NEUROLOGY
- CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival
- (2014) T. Skillback et al. NEUROLOGY
- Low clinical diagnostic accuracy of early vs advanced Parkinson disease: Clinicopathologic study
- (2014) C. H. Adler et al. NEUROLOGY
- Discovery of a Biomarker and Lead Small Molecules to Target r(GGGGCC)-Associated Defects in c9FTD/ALS
- (2014) Zhaoming Su et al. NEURON
- Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
- (2014) Stephen Salloway et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
- (2014) Rachelle S. Doody et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diurnal Patterns of Soluble Amyloid Precursor Protein Metabolites in the Human Central Nervous System
- (2014) Justyna A. Dobrowolska et al. PLoS One
- Memory Concerns, Memory Performance and Risk of Dementia in Patients with Mild Cognitive Impairment
- (2014) Steffen Wolfsgruber et al. PLoS One
- Novel plasma biomarker surrogating cerebral amyloid deposition
- (2014) Naoki KANEKO et al. PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- Prognostic classification of mild cognitive impairment and Alzheimer׳s disease: MRI independent component analysis
- (2014) Auriel A. Willette et al. PSYCHIATRY RESEARCH-NEUROIMAGING
- Longitudinal Change in CSF Biomarkers in Autosomal-Dominant Alzheimer's Disease
- (2014) A. M. Fagan et al. Science Translational Medicine
- Amyloid-beta 42 adsorption following serial tube transfer
- (2014) Jamie Toombs et al. Alzheimers Research & Therapy
- Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson’s disease with dementia and dementia with Lewy bodies compared to Alzheimer’s disease
- (2014) Oskar Hansson et al. Alzheimers Research & Therapy
- β-site amyloid precursor protein-cleaving enzyme 1(BACE1) inhibitor treatment induces Aβ5-X peptides through alternative amyloid precursor protein cleavage
- (2014) Erik Portelius et al. Alzheimers Research & Therapy
- Detection of Misfolded Aβ Oligomers for Sensitive Biochemical Diagnosis of Alzheimer’s Disease
- (2014) Natalia Salvadores et al. Cell Reports
- Limited role of free TDP-43 as a diagnostic tool in neurodegenerative diseases
- (2014) Emily Feneberg et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Diagnostic Performance of Cerebrospinal Fluid Total Tau and Phosphorylated Tau in Creutzfeldt-Jakob Disease
- (2014) Tobias Skillbäck et al. JAMA Neurology
- Associations Between Cerebral Small-Vessel Disease and Alzheimer Disease Pathology as Measured by Cerebrospinal Fluid Biomarkers
- (2014) Maartje I. Kester et al. JAMA Neurology
- Synergistic Effect of β-Amyloid and Neurodegeneration on Cognitive Decline in Clinically Normal Individuals
- (2014) Elizabeth C. Mormino et al. JAMA Neurology
- Nucleic Acid Ligands With Protein-like Side Chains: Modified Aptamers and Their Use as Diagnostic and Therapeutic Agents
- (2014) John C Rohloff et al. Molecular Therapy-Nucleic Acids
- Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognition
- (2014) Jon B Toledo et al. Acta Neuropathologica Communications
- Longitudinal change in CSF Tau and Aβ biomarkers for up to 48 months in ADNI
- (2013) Jon B. Toledo et al. ACTA NEUROPATHOLOGICA
- Disclosure of amyloid imaging results to research participants: Has the time come?
- (2013) Jennifer H. Lingler et al. Alzheimers & Dementia
- A novel BACE inhibitor (PF-05297909): A two-part adaptive design to evaluate safety, pharmacokinetics and pharmacodynamics for modifying beta-amyloid in a first-in-human study
- (2013) Joanne Bell et al. Alzheimers & Dementia
- CSF biomarker variability in the Alzheimer's Association quality control program
- (2013) Niklas Mattsson et al. Alzheimers & Dementia
- Gray matter atrophy pattern in elderly with subjective memory impairment
- (2013) Jessica Peter et al. Alzheimers & Dementia
- The future of blood-based biomarkers for Alzheimer's disease
- (2013) Kim Henriksen et al. Alzheimers & Dementia
- Association of plasma and cortical amyloid beta is modulated by APOE ε4 status
- (2013) Shanker Swaminathan et al. Alzheimers & Dementia
- Diagnosing Alzheimer's disease: A systematic review of economic evaluations
- (2013) Ron L.H. Handels et al. Alzheimers & Dementia
- Comparing positron emission tomography imaging and cerebrospinal fluid measurements of β-amyloid
- (2013) Susan M. Landau et al. ANNALS OF NEUROLOGY
- Anti-amyloid β autoantibodies in cerebral amyloid angiopathy-related inflammation: Implications for amyloid-modifying therapies
- (2013) Fabrizio Piazza et al. ANNALS OF NEUROLOGY
- Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration
- (2013) Carole S. Scherling et al. ANNALS OF NEUROLOGY
- Neuroimaging and Other Biomarkers for Alzheimer's Disease: The Changing Landscape of Early Detection
- (2013) Shannon L. Risacher et al. Annual Review of Clinical Psychology
- Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: A long-range point of view beyond 2020
- (2013) Harald Hampel et al. BIOCHEMICAL PHARMACOLOGY
- Cerebrospinal fluid neurofilament light chain protein levels in subtypes of frontotemporal dementia
- (2013) Maria Landqvist Waldö et al. BMC Neurology
- Treatment for mild cognitive impairment: systematic review
- (2013) Claudia Cooper et al. BRITISH JOURNAL OF PSYCHIATRY
- Safety and Pharmacology of a Single Intravenous Dose of Ponezumab in Subjects With Mild-to-Moderate Alzheimer Disease
- (2013) Jaren W. Landen et al. CLINICAL NEUROPHARMACOLOGY
- Mortality and Treatment Costs have a Great Impact on the Cost- Effectiveness of Disease Modifying Treatment in Alzheimer’s Disease - A Simulation Study
- (2013) Anders Skoldunger et al. Current Alzheimer Research
- Safety and pharmacokinetics of PF-04360365 following a single-dose intravenous infusion in Japanese subjects with mild-to-moderate Alzheimerâs disease: a multicenter, randomized, double-blind, placebo-controlled, dose-escalation study
- (2013) Izuru Miyoshi et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Costs of diagnosing dementia: results from SveDem, the Swedish Dementia Registry
- (2013) Anders Wimo et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Plasma phosphorylated TDP-43 levels are elevated in patients with frontotemporal dementia carrying a C9orf72 repeat expansion or a GRN mutation
- (2013) M. Suarez-Calvet et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Submandibular Gland Biopsy for the Diagnosis of Parkinson Disease
- (2013) Thomas G. Beach et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Pre-analytical factors influencing the stability of cerebrospinal fluid proteins
- (2013) Anja H. Simonsen et al. JOURNAL OF NEUROSCIENCE METHODS
- Multiplexed single molecule immunoassays
- (2013) David M. Rissin et al. LAB ON A CHIP
- Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study
- (2013) Stephanie JB Vos et al. LANCET NEUROLOGY
- Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
- (2013) Clifford R Jack et al. LANCET NEUROLOGY
- Alpha-synuclein Post-translational Modifications as Potential Biomarkers for Parkinson Disease and Other Synucleinopathies
- (2013) Adrien W. Schmid et al. MOLECULAR & CELLULAR PROTEOMICS
- ATP5H/KCTD2 locus is associated with Alzheimer's disease risk
- (2013) M Boada et al. MOLECULAR PSYCHIATRY
- CSF biomarkers for Alzheimer’s pathology and the effect size of APOE ɛ4
- (2013) U Andreasson et al. MOLECULAR PSYCHIATRY
- A blood-based predictor for neocortical Aβ burden in Alzheimer’s disease: results from the AIBL study
- (2013) S C Burnham et al. MOLECULAR PSYCHIATRY
- The glial marker YKL-40 is decreased in synucleinopathies
- (2013) Bob Olsson et al. MOVEMENT DISORDERS
- Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
- (2013) Jean-Charles Lambert et al. NATURE GENETICS
- Meta-analysis methods for genome-wide association studies and beyond
- (2013) Evangelos Evangelou et al. NATURE REVIEWS GENETICS
- Aβ-independent processes—rethinking preclinical AD
- (2013) Gaël Chételat Nature Reviews Neurology
- Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
- (2013) Chia-Chen Liu et al. Nature Reviews Neurology
- Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later
- (2013) C. M. Roe et al. NEUROLOGY
- Preclinical AD predicts decline in memory and executive functions in subjective complaints
- (2013) A. C. van Harten et al. NEUROLOGY
- Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease
- (2013) A. Prestia et al. NEUROLOGY
- Risk factors for dementia with Lewy bodies: A case-control study
- (2013) B. P. Boot et al. NEUROLOGY
- Criteria for the diagnosis of corticobasal degeneration
- (2013) M. J. Armstrong et al. NEUROLOGY
- Biomarkers in Amyloid-β Immunotherapy Trials in Alzheimer’s Disease
- (2013) Kaj Blennow et al. NEUROPSYCHOPHARMACOLOGY
- A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease
- (2013) Rachelle S. Doody et al. NEW ENGLAND JOURNAL OF MEDICINE
- Early Detection of Abnormal Prion Protein in Genetic Human Prion Diseases Now Possible Using Real-Time QUIC Assay
- (2013) Kazunori Sano et al. PLoS One
- Alzheimer’s Disease: Analyzing the Missing Heritability
- (2013) Perry G. Ridge et al. PLoS One
- Neurokinin3 receptor as a target to predict and improve learning and memory in the aged organism
- (2013) M. A. de Souza Silva et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Diagnosis and management of Alzheimer's disease: Past, present and future ethical issues
- (2013) S. Gauthier et al. PROGRESS IN NEUROBIOLOGY
- A review of quality of life after predictive testing for and earlier identification of neurodegenerative diseases
- (2013) Jane S. Paulsen et al. PROGRESS IN NEUROBIOLOGY
- Alzheimer’s disease mutations in APP but not γ-secretase modulators affect epsilon-cleavage-dependent AICD production
- (2013) Mitko Dimitrov et al. Nature Communications
- Brain Imaging in Alzheimer Disease
- (2013) K. A. Johnson et al. Cold Spring Harbor Perspectives in Medicine
- Mechanisms, models and biomarkers in amyotrophic lateral sclerosis
- (2013) Martin R. Turner et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Clinical and multimodal biomarker correlates of ADNI neuropathological findings
- (2013) Jon B Toledo et al. Acta Neuropathologica Communications
- Consensus classification of human prion disease histotypes allows reliable identification of molecular subtypes: an inter-rater study among surveillance centres in Europe and USA
- (2012) Piero Parchi et al. ACTA NEUROPATHOLOGICA
- CSF biomarkers cutoffs: the importance of coincident neuropathological diseases
- (2012) Jon B. Toledo et al. ACTA NEUROPATHOLOGICA
- Pharmacokinetics and Pharmacodynamics of CHF5074 After Short-term Administration in Healthy Subjects
- (2012) Bruno P. Imbimbo et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- Cognition, hippocampal volume and fibrillar Aβ burden as predictors of cognitive decline: Three-year follow-up results from AIBL
- (2012) Christopher Rowe et al. Alzheimers & Dementia
- Safety and biomarker effects of solanezumab in patients with Alzheimer’s disease
- (2012) Martin Farlow et al. Alzheimers & Dementia
- Development of biomarkers to chart all Alzheimer’s disease stages: The royal road to cutting the therapeutic Gordian Knot
- (2012) Harald Hampel et al. Alzheimers & Dementia
- The influence of insulin infusion on the metabolism of amyloid β peptides in plasma
- (2012) Monika Karczewska-Kupczewska et al. Alzheimers & Dementia
- Systematic review of the body of evidence for the use of biomarkers in the diagnosis of dementia
- (2012) Anna H. Noel-Storr et al. Alzheimers & Dementia
- Global standardization measurement of cerebral spinal fluid for Alzheimer's disease: An update from the Alzheimer's Association Global Biomarkers Consortium
- (2012) Maria C. Carrillo et al. Alzheimers & Dementia
- Cerebrospinal fluid Aβ42 is the best predictor of clinical progression in patients with subjective complaints
- (2012) Argonde C. van Harten et al. Alzheimers & Dementia
- Neuropathologic substrates of Parkinson disease dementia
- (2012) David J. Irwin et al. ANNALS OF NEUROLOGY
- Meta-analysis of early nonmotor features and risk factors for Parkinson disease
- (2012) Alastair J. Noyce et al. ANNALS OF NEUROLOGY
- Real time quaking-induced conversion analysis of cerebrospinal fluid in sporadic Creutzfeldt-Jakob disease
- (2012) Lynne I. McGuire et al. ANNALS OF NEUROLOGY
- Cerebrospinal Fluid Aβ and Tau Level Fluctuation in an Older Clinical Cohort
- (2012) Abhay Moghekar ARCHIVES OF NEUROLOGY
- Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and/or Parkinsonian Disorders
- (2012) Sara Hall et al. ARCHIVES OF NEUROLOGY
- Blood-Based Protein Biomarkers for Diagnosis of Alzheimer Disease
- (2012) James D. Doecke ARCHIVES OF NEUROLOGY
- Effect of Immunotherapy With Bapineuzumab on Cerebrospinal Fluid Biomarker Levels in Patients With Mild to Moderate Alzheimer Disease
- (2012) Henrik Zetterberg ARCHIVES OF NEUROLOGY
- Recommendations to standardize preanalytical confounding factors in Alzheimer’s and Parkinson’s disease cerebrospinal fluid biomarkers: an update
- (2012) Marta del Campo et al. Biomarkers in Medicine
- Neurochemical dementia diagnostics for Alzheimer’s disease and other dementias: an ISO 15189 perspective
- (2012) Johanna Waedt et al. Biomarkers in Medicine
- Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt–Jakob disease and rapid dementias: a longitudinal multicentre study over 10 years
- (2012) Katharina Stoeck et al. BRAIN
- Effects of Single Doses of Avagacestat (BMS-708163) on Cerebrospinal Fluid Aβ Levels in Healthy Young Men
- (2012) Gary Tong et al. CLINICAL DRUG INVESTIGATION
- Frontotemporal Lobar Degeneration
- (2012) Rachel E. Seltman et al. CNS DRUGS
- Reviewing reasons for the decreased CSF Abeta42 concentration in Alzheimer
- (2012) Petra et al. Frontiers in Bioscience-Landmark
- To Know or Not to Know: An Update of the Literature on the Psychological and Behavioral Impact of Genetic Testing for Alzheimer Disease Risk
- (2012) Belinda Rahman et al. Genetic Testing and Molecular Biomarkers
- Elevated Levels of α-Synuclein Oligomer in the Cerebrospinal Fluid of Drug-Naïve Patients with Parkinson's Disease
- (2012) Min Jeong Park et al. Journal of Clinical Neurology
- Validity of the Five-Word Test for the Evaluation of Verbal Episodic Memory and Dementia in a Memory Clinic Setting
- (2012) Eric Mormont et al. JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY
- α-Synuclein in human cerebrospinal fluid is principally derived from neurons of the central nervous system
- (2012) Brit Mollenhauer et al. JOURNAL OF NEURAL TRANSMISSION
- Interest of CSF biomarker analysis in possible cerebral amyloid angiopathy cases defined by the modified Boston criteria
- (2012) Dimitri Renard et al. JOURNAL OF NEUROLOGY
- Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis
- (2012) K. B. Boylan et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study
- (2012) Bengt Winblad et al. LANCET NEUROLOGY
- Inflammation and neurovascular changes in amyotrophic lateral sclerosis
- (2012) M.C. Evans et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- The amyloid-β isoform pattern in cerebrospinal fluid in familial PSEN1 M139T- and L286P-associated Alzheimer's disease
- (2012) ERIK PORTELIUS et al. Molecular Medicine Reports
- Alpha-Synuclein Posttranslational Modification and Alternative Splicing as a Trigger for Neurodegeneration
- (2012) Katrin Beyer et al. MOLECULAR NEUROBIOLOGY
- High frequency of potentially pathogenic SORL1 mutations in autosomal dominant early-onset Alzheimer disease
- (2012) C Pottier et al. MOLECULAR PSYCHIATRY
- Is alpha-synuclein in the colon a biomarker for premotor Parkinson's Disease? Evidence from 3 cases
- (2012) Kathleen M. Shannon et al. MOVEMENT DISORDERS
- Neurofilaments as biomarkers in multiple sclerosis
- (2012) Charlotte E Teunissen et al. Multiple Sclerosis Journal
- Advances in understanding the molecular basis of frontotemporal dementia
- (2012) Rosa Rademakers et al. Nature Reviews Neurology
- Plasma ß-Amyloid Levels in Cerebral Amyloid Angiopathy-Associated Hemorrhagic Stroke
- (2012) Mar Hernandez-Guillamon et al. Neurodegenerative Diseases
- Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease
- (2012) D. S. Knopman et al. NEUROLOGY
- Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease
- (2012) M. Wagner et al. NEUROLOGY
- Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease
- (2012) W. T. Hu et al. NEUROLOGY
- Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
- (2012) Randall J. Bateman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Variant of TREM2 Associated with the Risk of Alzheimer's Disease
- (2012) Thorlakur Jonsson et al. NEW ENGLAND JOURNAL OF MEDICINE
- TREM2 Variants in Alzheimer's Disease
- (2012) Rita Guerreiro et al. NEW ENGLAND JOURNAL OF MEDICINE
- BACE1 Inhibition Induces a Specific Cerebrospinal Fluid β-Amyloid Pattern That Identifies Drug Effects in the Central Nervous System
- (2012) Niklas Mattsson et al. PLoS One
- Rare Variants in APP, PSEN1 and PSEN2 Increase Risk for AD in Late-Onset Alzheimer's Disease Families
- (2012) Carlos Cruchaga et al. PLoS One
- Cost-Effectiveness of Magnetic Resonance Imaging with a New Contrast Agent for the Early Diagnosis of Alzheimer's Disease
- (2012) Maria Biasutti et al. PLoS One
- Blood and plasma-based proteomic biomarker research in Alzheimer's disease
- (2012) Simone Lista et al. PROGRESS IN NEUROBIOLOGY
- Phosphorylated -Synuclein in Parkinson's Disease
- (2012) Y. Wang et al. Science Translational Medicine
- A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid
- (2012) J. J. Iliff et al. Science Translational Medicine
- Development of Positron Emission Tomography β-Amyloid Plaque Imaging Agents
- (2012) Chester A. Mathis et al. SEMINARS IN NUCLEAR MEDICINE
- The emergence of diagnostic imaging technologies in breast cancer: discovery, regulatory approval, reimbursement, and adoption in clinical guidelines
- (2012) Laura S. Gold et al. CANCER IMAGING
- SOD1 in Cerebral Spinal Fluid as a Pharmacodynamic Marker for Antisense Oligonucleotide Therapy
- (2012) Leah Winer et al. JAMA Neurology
- APOE ϵ4 Increases Risk for Dementia in Pure Synucleinopathies
- (2012) Debby Tsuang et al. JAMA Neurology
- Alzheimer’s disease is not “brain aging”: neuropathological, genetic, and epidemiological human studies
- (2011) Peter T. Nelson et al. ACTA NEUROPATHOLOGICA
- Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI
- (2011) Leslie M. Shaw et al. ACTA NEUROPATHOLOGICA
- National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach
- (2011) Thomas J. Montine et al. ACTA NEUROPATHOLOGICA
- Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Clifford R. Jack et al. Alzheimers & Dementia
- Biomarkers in Alzheimer's disease drug development
- (2011) Jeffrey L. Cummings Alzheimers & Dementia
- The Alzheimer’s Association external quality control program for cerebrospinal fluid biomarkers
- (2011) Niklas Mattsson et al. Alzheimers & Dementia
- Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Marilyn S. Albert et al. Alzheimers & Dementia
- Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative
- (2011) Hugo Vanderstichele et al. Alzheimers & Dementia
- Treatable neurological disorders misdiagnosed as Creutzfeldt-Jakob disease
- (2011) Numthip Chitravas et al. ANNALS OF NEUROLOGY
- Amyloid-beta plaque growth in cognitively normal adults: Longitudinal [11C]Pittsburgh compound B data
- (2011) Andrei G. Vlassenko et al. ANNALS OF NEUROLOGY
- Cerebral amyloid angiopathy in the elderly
- (2011) Anand Viswanathan et al. ANNALS OF NEUROLOGY
- An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease
- (2011) Clifford R. Jack et al. ANNALS OF NEUROLOGY
- Longitudinal Change of Biomarkers in Cognitive Decline
- (2011) Raymond Y. Lo ARCHIVES OF NEUROLOGY
- Ecology of the Aging Human Brain
- (2011) Joshua A. Sonnen ARCHIVES OF NEUROLOGY
- PET amyloid-beta imaging in preclinical Alzheimer's disease
- (2011) Andrei G. Vlassenko et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- α-Synuclein misfolding and Parkinson's disease
- (2011) Leonid Breydo et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Salivary α-synuclein and DJ-1: potential biomarkers for Parkinson's disease
- (2011) Ivana Devic et al. BRAIN
- Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
- (2011) Katya Rascovsky et al. BRAIN
- Preanalytical quality improvement: from dream to reality
- (2011) Giuseppe Lippi et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Tau and p-tau as CSF biomarkers in dementia: a meta-analysis
- (2011) Argonde C. van Harten et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Genetics of Alzheimer's disease: new evidences for an old hypothesis?
- (2011) Jean-Charles Lambert et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- γ-Secretase Substrates and their Implications for Drug Development in Alzheimer's Disease
- (2011) Alberto Lleo et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- A Blood-Based Algorithm for the Detection of Alzheimer’s Disease
- (2011) Sid E. O’Bryant et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Neurochemical dementia diagnostics in Alzheimer’s disease: where are we now and where are we going?
- (2011) Piotr Lewczuk et al. Expert Review of Proteomics
- Genetic counseling and testing for Alzheimer disease: Joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors
- (2011) Jill S Goldman et al. GENETICS IN MEDICINE
- The transition to dementia – individual and family experiences of receiving a diagnosis: a review
- (2011) Louise Robinson et al. INTERNATIONAL PSYCHOGERIATRICS
- Biomarker candidates of neurodegeneration in Parkinson’s disease for the evaluation of disease-modifying therapeutics
- (2011) Manfred Gerlach et al. JOURNAL OF NEURAL TRANSMISSION
- Combination of neurofilament heavy chain and complement C3 as CSF biomarkers for ALS
- (2011) Jeban Ganesalingam et al. JOURNAL OF NEUROCHEMISTRY
- Misfolded superoxide dismutase-1 in CSF from amyotrophic lateral sclerosis patients
- (2011) Per Zetterström et al. JOURNAL OF NEUROCHEMISTRY
- Measurement of Aβ1-42 in cerebrospinal fluid is influenced by matrix effects
- (2011) J. Randall Slemmon et al. JOURNAL OF NEUROCHEMISTRY
- Aβ-Degrading Enzymes: Potential for Treatment of Alzheimer Disease
- (2011) James Scott Miners et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- In Vivo Microdialysis Reveals Age-Dependent Decrease of Brain Interstitial Fluid Tau Levels in P301S Human Tau Transgenic Mice
- (2011) K. Yamada et al. JOURNAL OF NEUROSCIENCE
- Amyotrophic lateral sclerosis
- (2011) Matthew C Kiernan et al. LANCET
- α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study
- (2011) Brit Mollenhauer et al. LANCET NEUROLOGY
- Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study
- (2011) Melissa E Murray et al. LANCET NEUROLOGY
- Multiplexed Homogeneous Proximity Ligation Assays for High-throughput Protein Biomarker Research in Serological Material
- (2011) Martin Lundberg et al. MOLECULAR & CELLULAR PROTEOMICS
- APOE and Alzheimer disease: a major gene with semi-dominant inheritance
- (2011) E Genin et al. MOLECULAR PSYCHIATRY
- Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease
- (2011) Adam C Naj et al. NATURE GENETICS
- Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
- (2011) Paul Hollingworth et al. NATURE GENETICS
- Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion
- (2011) Ryuichiro Atarashi et al. NATURE MEDICINE
- Hourly variability of cerebrospinal fluid biomarkers in Alzheimer's disease subjects and healthy older volunteers
- (2011) Diane Slats et al. NEUROBIOLOGY OF AGING
- Microbleeds relate to altered amyloid-beta metabolism in Alzheimer's disease
- (2011) Jeroen D.C. Goos et al. NEUROBIOLOGY OF AGING
- CSF soluble amyloid precursor proteins in the diagnosis of incipient Alzheimer disease
- (2011) R. Perneczky et al. NEUROLOGY
- Classification of primary progressive aphasia and its variants
- (2011) M. L. Gorno-Tempini et al. NEUROLOGY
- Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS
- (2011) Mariely DeJesus-Hernandez et al. NEURON
- CSF α-synuclein concentrations do not fluctuate over hours and are not correlated to amyloid β in humans
- (2011) Petra E. Spies et al. NEUROSCIENCE LETTERS
- Diagnosis of Alzheimer's Disease Based on Disease-Specific Autoantibody Profiles in Human Sera
- (2011) Eric Nagele et al. PLoS One
- A Blood-Based Screening Tool for Alzheimer's Disease That Spans Serum and Plasma: Findings from TARC and ADNI
- (2011) Sid E. O'Bryant et al. PLoS One
- Interleukin-17 and interleukin-23 are elevated in serum and cerebrospinal fluid of patients with ALS: a reflection of Th17 cells activation?
- (2010) M. Rentzos et al. ACTA NEUROLOGICA SCANDINAVICA
- Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson’s disease
- (2010) Kelly Del Tredici et al. ACTA NEUROPATHOLOGICA
- The Alzheimer's Disease Neuroimaging Initiative: Annual change in biomarkers and clinical outcomes
- (2010) Laurel A. Beckett et al. Alzheimers & Dementia
- Elevated CSF TDP-43 levels in amyotrophic lateral sclerosis: Specificity, sensitivity, and a possible prognostic value
- (2010) Yu-Ichi Noto et al. Amyotrophic Lateral Sclerosis
- Cerebral amyloid angiopathy pathology and cognitive domains in older persons
- (2010) Zoe Arvanitakis et al. ANNALS OF NEUROLOGY
- Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab
- (2010) Martin Gunnarsson et al. ANNALS OF NEUROLOGY
- A Serum Protein–Based Algorithm for the Detection of Alzheimer Disease
- (2010) Sid E. O’Bryant ARCHIVES OF NEUROLOGY
- Correlation of Longitudinal Cerebrospinal Fluid Biomarkers With Cognitive Decline in Healthy Older Adults
- (2010) Erik Stomrud et al. ARCHIVES OF NEUROLOGY
- DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson’s disease
- (2010) Zhen Hong et al. BRAIN
- Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer's disease
- (2010) Annika Thorsell et al. BRAIN RESEARCH
- Nonspecific binding of Aβ42 to polypropylene tubes and the effect of Tween-20
- (2010) Arnaldo M. Pica-Mendez et al. CLINICA CHIMICA ACTA
- Safety and Changes in Plasma and Cerebrospinal Fluid Amyloid β After a Single Administration of an Amyloid β Monoclonal Antibody in Subjects With Alzheimer Disease
- (2010) Eric R. Siemers et al. CLINICAL NEUROPHARMACOLOGY
- Frontotemporal Lobar Degeneration
- (2010) Gil D. Rabinovici et al. CNS DRUGS
- Genome-wide Analysis of Genetic Loci Associated With Alzheimer Disease
- (2010) Sudha Seshadri JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Different profiles of Alzheimer’s disease cerebrospinal fluid biomarkers in controls and subjects with subjective memory complaints
- (2010) Anna Antonell et al. JOURNAL OF NEURAL TRANSMISSION
- CSF chemokine alterations related to the clinical course of amyotrophic lateral sclerosis
- (2010) Takahisa Tateishi et al. JOURNAL OF NEUROIMMUNOLOGY
- An exploratory study of serum urate levels in patients with amyotrophic lateral sclerosis
- (2010) Stefano Zoccolella et al. JOURNAL OF NEUROLOGY
- Revising the definition of Alzheimer's disease: a new lexicon
- (2010) Bruno Dubois et al. LANCET NEUROLOGY
- Synthesis and Characterization of Polycarbonates by Melt Phase Interchange Reactions of Alkylene and Arylene Diacetates with Alkylene and Arylene Diphenyl Dicarbonates
- (2010) Bassam A. Sweileh et al. MOLECULES
- Alpha-synuclein immunoreactivity in minor salivary gland biopsies of Parkinson's disease patients
- (2010) Maria Graciela Cersósimo et al. MOVEMENT DISORDERS
- Discovery and verification of amyotrophic lateral sclerosis biomarkers by proteomics
- (2010) Henrik Ryberg et al. MUSCLE & NERVE
- Plasma biomarkers associated with ALS and their relationship to iron homeostasis
- (2010) Ryan M. Mitchell et al. MUSCLE & NERVE
- Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations
- (2010) David M Rissin et al. NATURE BIOTECHNOLOGY
- Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives
- (2010) Harald Hampel et al. NATURE REVIEWS DRUG DISCOVERY
- Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
- (2010) Kaj Blennow et al. Nature Reviews Neurology
- Serial MRI and CSF biomarkers in normal aging, MCI, and AD
- (2010) P. Vemuri et al. NEUROLOGY
- Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy
- (2010) J. Linn et al. NEUROLOGY
- Review: Sporadic cerebral amyloid angiopathy
- (2010) J. Attems et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Colonic Biopsies to Assess the Neuropathology of Parkinson's Disease and Its Relationship with Symptoms
- (2010) Thibaud Lebouvier et al. PLoS One
- Cystatin C: A Candidate Biomarker for Amyotrophic Lateral Sclerosis
- (2010) Meghan E. Wilson et al. PLoS One
- Genetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer's Disease
- (2010) Lesley Jones et al. PLoS One
- Truncated -amyloid peptide channels provide an alternative mechanism for Alzheimer's Disease and Down syndrome
- (2010) H. Jang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Multicentre variability of MRI-based medial temporal lobe volumetry in Alzheimer's disease
- (2010) Stefan J. Teipel et al. PSYCHIATRY RESEARCH-NEUROIMAGING
- Identifying and validating biomarkers for Alzheimer's disease
- (2010) Christian Humpel TRENDS IN BIOTECHNOLOGY
- A novel Aβ isoform pattern in CSF reflects γ-secretase inhibition in Alzheimer disease
- (2010) Erik Portelius et al. Alzheimers Research & Therapy
- Incidence and spectrum of sporadic Creutzfeldt–Jakob disease variants with mixed phenotype and co-occurrence of PrPSc types: an updated classification
- (2009) Piero Parchi et al. ACTA NEUROPATHOLOGICA
- Cerebrospinal fluid amyloid β40is decreased in cerebral amyloid angiopathy
- (2009) Marcel M. Verbeek et al. ANNALS OF NEUROLOGY
- A γ-secretase inhibitor decreases amyloid-β production in the central nervous system
- (2009) Randall J. Bateman et al. ANNALS OF NEUROLOGY
- Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects
- (2009) Leslie M. Shaw et al. ANNALS OF NEUROLOGY
- APOEpredicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging
- (2009) John C. Morris et al. ANNALS OF NEUROLOGY
- Identifying Early Markers of Alzheimer's Disease using Quantitative Multiplex Proteomic Immunoassay Panels
- (2009) Holly D. Soares et al. Annals of the New York Academy of Sciences
- Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease
- (2009) Clifford R. Jack et al. BRAIN
- Clearance of Amyloid-β Peptide Across the Blood-Brain Barrier: Implication for Therapies in Alzheimers Disease
- (2009) R. Deane et al. CNS & Neurological Disorders-Drug Targets
- Cognitive and Noncognitive Neurological Features of Young-Onset Dementia
- (2009) Brendan J. Kelley et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Early and Differential Diagnosis of Dementia and Mild Cognitive Impairment
- (2009) Johannes Kornhuber et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Cerebrospinal fluid tau and ptau181increase with cortical amyloid deposition in cognitively normal individuals: Implications for future clinical trials of Alzheimer's disease
- (2009) Anne M. Fagan et al. EMBO Molecular Medicine
- Amyloid β peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexing
- (2009) P. Lewczuk et al. EXPERIMENTAL NEUROLOGY
- Verbal cued recall as a predictor of conversion to Alzheimer's disease in Mild Cognitive Impairment
- (2009) E. Dierckx et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- The cost of diagnosing dementia in a community setting
- (2009) Erik Jedenius et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment
- (2009) Niklas Mattsson JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Decision analysis to complete diagnostic research by closing the gap between test characteristics and cost-effectiveness
- (2009) Joanna D. Schaafsma et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Neurochemical dementia diagnostics: a simple algorithm for interpretation of the CSF biomarkers
- (2009) Piotr Lewczuk et al. JOURNAL OF NEURAL TRANSMISSION
- Low uric acid levels in serum of patients with ALS: Further evidence for oxidative stress?
- (2009) D. Keizman et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study
- (2009) Pieter Jelle Visser et al. LANCET NEUROLOGY
- Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis
- (2009) Sarah T Pendlebury et al. LANCET NEUROLOGY
- Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
- (2009) Clifford R Jack et al. LANCET NEUROLOGY
- Proposals for a Phased Evaluation of Medical Tests
- (2009) Jeroen G. Lijmer et al. MEDICAL DECISION MAKING
- Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease
- (2009) Jean-Charles Lambert et al. NATURE GENETICS
- Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
- (2009) Denise Harold et al. NATURE GENETICS
- Added diagnostic value of CSF biomarkers in differential dementia diagnosis
- (2009) Nathalie Le Bastard et al. NEUROBIOLOGY OF AGING
- Improved discrimination of autopsy-confirmed Alzheimer's disease (AD) from non-AD dementias using CSF P-tau181P
- (2009) Karen Koopman et al. NEUROCHEMISTRY INTERNATIONAL
- MRI and CSF biomarkers in normal, MCI, and AD subjects: Diagnostic discrimination and cognitive correlations
- (2009) P. Vemuri et al. NEUROLOGY
- A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking
- (2009) C. E. Teunissen et al. NEUROLOGY
- Cystatin C in cerebrospinal fluid as a biomarker of ALS
- (2009) Sachiko Tsuji-Akimoto et al. NEUROSCIENCE LETTERS
- Disclosure ofAPOEGenotype for Risk of Alzheimer's Disease
- (2009) Robert C. Green et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genomewide Association Studies and Human Disease
- (2009) John Hardy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Patients With Alzheimer Disease With Multiple Microbleeds
- (2009) Jeroen D.C. Goos et al. STROKE
- Increased TDP-43 protein in cerebrospinal fluid of patients with amyotrophic lateral sclerosis
- (2008) Takashi Kasai et al. ACTA NEUROPATHOLOGICA
- TDP-43 in Cerebrospinal Fluid of Patients With Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
- (2008) Petra Steinacker et al. ARCHIVES OF NEUROLOGY
- Phase 2 Safety Trial Targeting Amyloid β Production With a γ-Secretase Inhibitor in Alzheimer Disease
- (2008) Adam S. Fleisher et al. ARCHIVES OF NEUROLOGY
- Peptides and proteins in plasma and cerebrospinal fluid as biomarkers for the prediction, diagnosis, and monitoring of therapeutic efficacy of Alzheimer's disease
- (2008) Christopher D. Aluise et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- From Presenilinase to γ-Secretase, Cleave to Capacitate
- (2008) Weiming Xia Current Alzheimer Research
- Direct quantification of CSF α-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration
- (2008) Brit Mollenhauer et al. EXPERIMENTAL NEUROLOGY
- Pathological lesions in colonic biopsies during Parkinson's disease
- (2008) T Lebouvier et al. GUT
- Hyper-high-sensitivity wash-free magnetoreduction assay on biomolecules using high-Tc superconducting quantum interference devices
- (2008) J. J. Chieh et al. JOURNAL OF APPLIED PHYSICS
- Progranulin functions as a neurotrophic factor to regulate neurite outgrowth and enhance neuronal survival
- (2008) Philip Van Damme et al. JOURNAL OF CELL BIOLOGY
- Recall and recognition of verbal paired associates in early Alzheimer's disease
- (2008) G.J. LOWNDES et al. JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY
- Biomarkers in amyotrophic lateral sclerosis
- (2008) Martin R Turner et al. LANCET NEUROLOGY
- Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study
- (2008) P Lewczuk et al. MOLECULAR PSYCHIATRY
- Simplified ultrasensitive prion detection by recombinant PrP conversion with shaking
- (2008) Ryuichiro Atarashi et al. NATURE METHODS
- 14-3-3 CSF levels in sporadic Creutzfeldt–Jakob disease differ across molecular subtypes
- (2008) K. Gmitterová et al. NEUROBIOLOGY OF AGING
- Red Blood Cells Are the Major Source of Alpha-Synuclein in Blood
- (2008) Robin Barbour et al. Neurodegenerative Diseases
- Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degeneration
- (2008) R. Ghidoni et al. NEUROLOGY
- CSF biomarkers in frontotemporal lobar degeneration with known pathology
- (2008) H. Bian et al. NEUROLOGY
- A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis
- (2008) R. M. Mitchell et al. NEUROLOGY
- GATA transcription factors directly regulate the Parkinson's disease-linked gene -synuclein
- (2008) C. R. Scherzer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Neurochemical dementia diagnostics: State of the art and research perspectives
- (2008) Piotr Lewczuk et al. PROTEOMICS
- Mild cognitive impairment: coping with an uncertain label
- (2007) Liesbeth Joosten-Weyn Banningh et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia
- (2007) Sebastiaan Engelborghs et al. NEUROBIOLOGY OF AGING
- Hippocampal hypometabolism predicts cognitive decline from normal aging
- (2007) Lisa Mosconi et al. NEUROBIOLOGY OF AGING
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now